Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Clopidogrel Loading Dose Effects on Coronary Flow Reserve in ACS
NCT02032290Phase 4Unknown
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02032290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032290.